脑外伤患者脱水剂、甘露醇和浓盐的使用情况?

2021-07-08 MedSci原创 MedSci原创

《梅斯直播课:颅脑创伤临床救治及影像资料》——刘佰运

《梅斯直播课:颅脑创伤临床救治及影像资料》——刘佰运


回答问题7:脑外伤患者脱水剂、甘露醇和浓盐使用情况?

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1195219, encodeId=645f119521949, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00b23462159, createdName=130a765fm69暂无昵称, createdTime=Sat Feb 19 22:42:04 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1660852, encodeId=2b6116608526b, content=<a href='/topic/show?id=17b8268041b' target=_blank style='color:#2F92EE;'>#使用情况#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26804, encryptionId=17b8268041b, topicName=使用情况)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=169625169742, createdName=dzx0922897, createdTime=Sun Jan 16 11:55:27 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998701, encodeId=65e2998e0163, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160531/IMG574DA473DF46C6923.jpg, createdBy=e39768313, createdName=xzmynya, createdTime=Mon Jul 12 09:02:40 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295691, encodeId=c1fd1295691de, content=<a href='/topic/show?id=e02468846d4' target=_blank style='color:#2F92EE;'>#甘露醇#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68846, encryptionId=e02468846d4, topicName=甘露醇)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f73a255, createdName=medscijoin, createdTime=Sat Jul 10 06:55:27 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998104, encodeId=b7ee998104a0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201220/014c03c394784cdd8c81cb99814d2040/b1b170bf9f9342dbbd7b977397e74319.jpg, createdBy=230b5445121, createdName=肥狐jolie, createdTime=Sat Jul 10 00:32:12 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997674, encodeId=c27c99e6742b, content=哈哈,老大爷讲得生动, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200915/3bce101c7b8f4841bb5b26425228b7c2/8441a17fdd724b828538a4de39b5bef8.jpg, createdBy=15135417845, createdName=ms5000000356210338, createdTime=Thu Jul 08 20:46:47 CST 2021, time=2021-07-08, status=1, ipAttribution=)]
    2022-02-19 130a765fm69暂无昵称

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1195219, encodeId=645f119521949, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00b23462159, createdName=130a765fm69暂无昵称, createdTime=Sat Feb 19 22:42:04 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1660852, encodeId=2b6116608526b, content=<a href='/topic/show?id=17b8268041b' target=_blank style='color:#2F92EE;'>#使用情况#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26804, encryptionId=17b8268041b, topicName=使用情况)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=169625169742, createdName=dzx0922897, createdTime=Sun Jan 16 11:55:27 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998701, encodeId=65e2998e0163, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160531/IMG574DA473DF46C6923.jpg, createdBy=e39768313, createdName=xzmynya, createdTime=Mon Jul 12 09:02:40 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295691, encodeId=c1fd1295691de, content=<a href='/topic/show?id=e02468846d4' target=_blank style='color:#2F92EE;'>#甘露醇#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68846, encryptionId=e02468846d4, topicName=甘露醇)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f73a255, createdName=medscijoin, createdTime=Sat Jul 10 06:55:27 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998104, encodeId=b7ee998104a0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201220/014c03c394784cdd8c81cb99814d2040/b1b170bf9f9342dbbd7b977397e74319.jpg, createdBy=230b5445121, createdName=肥狐jolie, createdTime=Sat Jul 10 00:32:12 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997674, encodeId=c27c99e6742b, content=哈哈,老大爷讲得生动, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200915/3bce101c7b8f4841bb5b26425228b7c2/8441a17fdd724b828538a4de39b5bef8.jpg, createdBy=15135417845, createdName=ms5000000356210338, createdTime=Thu Jul 08 20:46:47 CST 2021, time=2021-07-08, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1195219, encodeId=645f119521949, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00b23462159, createdName=130a765fm69暂无昵称, createdTime=Sat Feb 19 22:42:04 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1660852, encodeId=2b6116608526b, content=<a href='/topic/show?id=17b8268041b' target=_blank style='color:#2F92EE;'>#使用情况#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26804, encryptionId=17b8268041b, topicName=使用情况)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=169625169742, createdName=dzx0922897, createdTime=Sun Jan 16 11:55:27 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998701, encodeId=65e2998e0163, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160531/IMG574DA473DF46C6923.jpg, createdBy=e39768313, createdName=xzmynya, createdTime=Mon Jul 12 09:02:40 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295691, encodeId=c1fd1295691de, content=<a href='/topic/show?id=e02468846d4' target=_blank style='color:#2F92EE;'>#甘露醇#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68846, encryptionId=e02468846d4, topicName=甘露醇)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f73a255, createdName=medscijoin, createdTime=Sat Jul 10 06:55:27 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998104, encodeId=b7ee998104a0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201220/014c03c394784cdd8c81cb99814d2040/b1b170bf9f9342dbbd7b977397e74319.jpg, createdBy=230b5445121, createdName=肥狐jolie, createdTime=Sat Jul 10 00:32:12 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997674, encodeId=c27c99e6742b, content=哈哈,老大爷讲得生动, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200915/3bce101c7b8f4841bb5b26425228b7c2/8441a17fdd724b828538a4de39b5bef8.jpg, createdBy=15135417845, createdName=ms5000000356210338, createdTime=Thu Jul 08 20:46:47 CST 2021, time=2021-07-08, status=1, ipAttribution=)]
    2021-07-12 xzmynya

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1195219, encodeId=645f119521949, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00b23462159, createdName=130a765fm69暂无昵称, createdTime=Sat Feb 19 22:42:04 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1660852, encodeId=2b6116608526b, content=<a href='/topic/show?id=17b8268041b' target=_blank style='color:#2F92EE;'>#使用情况#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26804, encryptionId=17b8268041b, topicName=使用情况)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=169625169742, createdName=dzx0922897, createdTime=Sun Jan 16 11:55:27 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998701, encodeId=65e2998e0163, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160531/IMG574DA473DF46C6923.jpg, createdBy=e39768313, createdName=xzmynya, createdTime=Mon Jul 12 09:02:40 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295691, encodeId=c1fd1295691de, content=<a href='/topic/show?id=e02468846d4' target=_blank style='color:#2F92EE;'>#甘露醇#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68846, encryptionId=e02468846d4, topicName=甘露醇)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f73a255, createdName=medscijoin, createdTime=Sat Jul 10 06:55:27 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998104, encodeId=b7ee998104a0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201220/014c03c394784cdd8c81cb99814d2040/b1b170bf9f9342dbbd7b977397e74319.jpg, createdBy=230b5445121, createdName=肥狐jolie, createdTime=Sat Jul 10 00:32:12 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997674, encodeId=c27c99e6742b, content=哈哈,老大爷讲得生动, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200915/3bce101c7b8f4841bb5b26425228b7c2/8441a17fdd724b828538a4de39b5bef8.jpg, createdBy=15135417845, createdName=ms5000000356210338, createdTime=Thu Jul 08 20:46:47 CST 2021, time=2021-07-08, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1195219, encodeId=645f119521949, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00b23462159, createdName=130a765fm69暂无昵称, createdTime=Sat Feb 19 22:42:04 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1660852, encodeId=2b6116608526b, content=<a href='/topic/show?id=17b8268041b' target=_blank style='color:#2F92EE;'>#使用情况#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26804, encryptionId=17b8268041b, topicName=使用情况)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=169625169742, createdName=dzx0922897, createdTime=Sun Jan 16 11:55:27 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998701, encodeId=65e2998e0163, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160531/IMG574DA473DF46C6923.jpg, createdBy=e39768313, createdName=xzmynya, createdTime=Mon Jul 12 09:02:40 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295691, encodeId=c1fd1295691de, content=<a href='/topic/show?id=e02468846d4' target=_blank style='color:#2F92EE;'>#甘露醇#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68846, encryptionId=e02468846d4, topicName=甘露醇)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f73a255, createdName=medscijoin, createdTime=Sat Jul 10 06:55:27 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998104, encodeId=b7ee998104a0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201220/014c03c394784cdd8c81cb99814d2040/b1b170bf9f9342dbbd7b977397e74319.jpg, createdBy=230b5445121, createdName=肥狐jolie, createdTime=Sat Jul 10 00:32:12 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997674, encodeId=c27c99e6742b, content=哈哈,老大爷讲得生动, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200915/3bce101c7b8f4841bb5b26425228b7c2/8441a17fdd724b828538a4de39b5bef8.jpg, createdBy=15135417845, createdName=ms5000000356210338, createdTime=Thu Jul 08 20:46:47 CST 2021, time=2021-07-08, status=1, ipAttribution=)]
    2021-07-10 肥狐jolie

    学习了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1195219, encodeId=645f119521949, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00b23462159, createdName=130a765fm69暂无昵称, createdTime=Sat Feb 19 22:42:04 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1660852, encodeId=2b6116608526b, content=<a href='/topic/show?id=17b8268041b' target=_blank style='color:#2F92EE;'>#使用情况#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26804, encryptionId=17b8268041b, topicName=使用情况)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=169625169742, createdName=dzx0922897, createdTime=Sun Jan 16 11:55:27 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998701, encodeId=65e2998e0163, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160531/IMG574DA473DF46C6923.jpg, createdBy=e39768313, createdName=xzmynya, createdTime=Mon Jul 12 09:02:40 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295691, encodeId=c1fd1295691de, content=<a href='/topic/show?id=e02468846d4' target=_blank style='color:#2F92EE;'>#甘露醇#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68846, encryptionId=e02468846d4, topicName=甘露醇)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f73a255, createdName=medscijoin, createdTime=Sat Jul 10 06:55:27 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998104, encodeId=b7ee998104a0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201220/014c03c394784cdd8c81cb99814d2040/b1b170bf9f9342dbbd7b977397e74319.jpg, createdBy=230b5445121, createdName=肥狐jolie, createdTime=Sat Jul 10 00:32:12 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997674, encodeId=c27c99e6742b, content=哈哈,老大爷讲得生动, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200915/3bce101c7b8f4841bb5b26425228b7c2/8441a17fdd724b828538a4de39b5bef8.jpg, createdBy=15135417845, createdName=ms5000000356210338, createdTime=Thu Jul 08 20:46:47 CST 2021, time=2021-07-08, status=1, ipAttribution=)]
    2021-07-08 ms5000000356210338

    哈哈,老大爷讲得生动

    0

相关资讯

Brain:丹麦百万人研究:多次脑外伤后,癫痫风险更高!

Brain:丹麦百万人研究:多次脑外伤后,癫痫风险更高!

JNNP:脑外伤后认知功能与日常生活功能的关系

外伤性脑损伤(TBI)是导致残疾的主要原因,这给个人和社会造成了巨大的负担。超过一半的轻度脑外伤患者在6个月时报告功能受损,更严重的是,残疾可能会持续多年。但是,认知障碍与日常功能之间的关系还不完全清

J Neurol Neurosur Ps:脑外伤患者精神药物和止痛药使用情况分析

颅脑损伤后使用精神药物和止痛药物的比例较高,建议定期进行医学随访并总结这些药物使用情况。

脑外伤患者常规抗癫痫时长

脑外伤患者常规抗癫痫一个周吗?

拓展阅读

甘露醇降颅内压,使用方法、剂量和注意事项,一文总结!

那么使用甘露醇降低颅内压时,给药剂量是0.25 g/kg还是0.5 g/kg?是连续输注还是脉冲式给药?

JAMA Network Open:3%高渗盐比甘露醇治疗儿童严重创伤性脑损伤高颅内压更有效

在颅内压升高期间,观察到高渗治疗有更大的疗效,3%高渗盐比甘露醇有更大的改善效果。

甘露醇全面使用手册--正确使用甘露醇建议收藏:

甘露醇输注方案包括连续输注或脉冲式给药,脉冲式给药较连续输注效果更好,常规推荐剂量为0.25~1g/kg体质量经外周或中心静脉导管在10~20min的时间内静脉输入。

甘露醇在急性脑血管疾病治疗中的应用技巧

急性脑血管病是指突然发病的脑血液循环障碍,其临床表现的特点是起病急骤,可出现弥散全脑病变的症状,如意识障碍、脑膜刺激征、颅内压增高等。在临床治疗中,急性脑血管疾病不论轻重,均存在不同程度的脑水肿,在目

甘油果糖脱水效果如何?

《梅斯直播课:颅脑创伤临床救治及影像资料》回答问题6

患儿刚出院就又入院,甘露醇的这个副作用,千万要注意

患儿因病毒性脑炎治疗1周后出院,第2日却因精神差、嗜睡再次入院,其原因是什么?应该怎样处理